Batu Biologics, an immuno-oncology company focused on the development and commercialization of novel therapies, announced on Monday the closing of its Regulation 506(c) equity crowdfunding offering on EquityNet after successfully securing $1.3 Million in funding. The funding round was launched in May 2017 and was… Read More
Batu Biologics wants to eradicate cancer, even in late stage cancer patients. The company has developed a promising drug called ValloVax that leverages the bodies immune system to recognize the blood cells feeding tumors and cutting them off. Basically starving cancer and saving the patient. Earlier… Read More
Using a fundraising approach seldom seen in the life sciences sector, Batu Biologics, an immunotherapy company working to develop the first anti-angiogenic cancer vaccine, has successfully raised $100,000 through crowdfunding giant, Indiegogo. Batu Biologics launched the crowdfunding campaign in June 2014 to fund the completion… Read More
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.Ok